Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 3537163, 25 pages
http://dx.doi.org/10.1155/2016/3537163
Review Article

Applicability of Isolates and Fractions of Plant Extracts in Murine Models in Type II Diabetes: A Systematic Review

1Department of Medicine and Nursing, Federal University of Viçosa, Viçosa, MG, Brazil
2Institute of Biomedical Science, Department of Structural Biology, Federal University of Alfenas, Alfenas, MG, Brazil
3Department of General Biology, Federal University of Viçosa, Viçosa, MG, Brazil
4Department of Animal Biology, Federal University of Viçosa, MG, Brazil

Received 16 March 2016; Accepted 11 May 2016

Academic Editor: Mohammed S. Razzaque

Copyright © 2016 Gabriela Diniz Pinto Coelho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y.-T. Jeong and C.-H. Song, “Antidiabetic activities of extract from Malva verticillata seed via the activation of AMP-activated protein kinase,” Journal of Microbiology and Biotechnology, vol. 21, no. 9, pp. 921–929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. L. G. Bowden, P. K. Maini, D. E. Moulton et al., “An ordinary differential equation model for full thickness wounds and the effects of diabetes,” Journal of Theoretical Biology, vol. 361, pp. 87–100, 2014. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at Scopus
  3. M. S. Dos Santos, M. N. Freitas, and F. de Oliveira Pinto, “O diabetes mellitus tipo 1 e tipo 2 e sua evolução no municipio de Quissamã-RJ,” Revista Científica Interdisciplinar, vol. 1, no. 1, pp. 119–192, 2014. View at Publisher · View at Google Scholar
  4. J. P. H. Wilding, L. Blonde, L. A. Leiter et al., “Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus,” Journal of Diabetes and Its Complications, vol. 29, no. 3, pp. 438–444, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Eddouks, A. Bidi, B. El Bouhali, L. Hajji, and N. A. Zeggwagh, “Antidiabetic plants improving insulin sensitivity,” Journal of Pharmacy and Pharmacology, vol. 66, no. 9, pp. 1197–1214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. International Diabetes Federation IDF, Diabetes Atlas. 6th edition, https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf
  7. International Diabetes Federation (IDF), Diabetes Atlas, 5th edition, 2011, https://www.idf.org/sites/default/files/Atlas-poster-2014_EN.pdf.
  8. Sociedade Brasileira de Endocrinologia e Metabologia (SBEM), Números do diabetes no Brasil, http://www.endocrino.org.br/numeros-do-diabetes-no-brasil/
  9. V. A. Ferreira and S. M. B. Campos, “Avanços farmacológicos no tratamento do diabetes tipo 2,” Brazilian Journal of Surgery and Clinical Research, vol. 8, pp. 72–78, 2014. View at Google Scholar
  10. M. J. Lawrence and G. D. Rees, “Microemulsion-based media as novel drug delivery systems,” Advanced Drug Delivery Reviews, vol. 45, no. 1, pp. 89–121, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. R. L. Rosa, A. L. V. Barcelos, and G. Bampi, “Investigação do uso de plantas medicinais no tratamento de indivíduos com diabetes melittus na cidade de Herval D' Oeste—SC,” Revista Brasileira de Plantas Medicinais, vol. 14, pp. 306–310, 2012. View at Google Scholar
  12. P. Nain, V. Saini, S. Sharma, and J. Nain, “Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 65–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. A. Abdel-Sattar, H. M. Abdallah, A. Khedr, A. B. Abdel-Naim, and I. A. Shehata, “Antihyperglycemic activity of Caralluma tuberculata in streptozotocin-induced diabetic rats,” Food and Chemical Toxicology, vol. 59, pp. 111–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. B. B. Petrovska, “Historical review of medicinal plants' usage,” Pharmacognosy Reviews, vol. 6, no. 11, pp. 1–5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Gadelha, “Estudo bibliográfico sobre o uso das plantas medicinais e fitoterápicos no Brasil,” Revista Verde de Agroecologia e Desenvolvimento Sustentável, vol. 8, pp. 208–212, 2013. View at Google Scholar
  16. A. M. Feijó, M. E. Bueno, T. Ceolin et al., “Plantas medicinais utilizadas por idosos com diagnóstico de Diabetes mellitus no tratamento dos sintomas da doença,” Revista Brasileira de Plantas Medicinais, vol. 14, no. 1, pp. 50–56, 2012. View at Publisher · View at Google Scholar
  17. W. Xu, Q. Zhou, J.-J. Yin, Y. Yao, and J.-L. Zhang, “Anti-diabetic effects of polysaccharides from Talinum triangulare in streptozotocin (STZ)-induced type 2 diabetic male mice,” International Journal of Biological Macromolecules, vol. 72, pp. 575–579, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. G. R. Schütz, A. S. S. Sant'ana, and S. G. Santana, “Política de periódicos nacionais em Educação Física para estudos de revisão/sistemática,” Revista Brasileira de Cineantropometria & Desempenho Humano, vol. 13, pp. 313–319, 2011. View at Google Scholar
  19. D. Moher, L. Shamseer, M. Clarke et al., “Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement,” Systematic Reviews, vol. 4, p. 1, 2015. View at Publisher · View at Google Scholar
  20. M. G. Pereira and T. F. Galvão, “Etapas de busca e seleção de artigos em revisões sistemáticas da literatura,” Epidemiologia e Serviços de Saúde, vol. 23, no. 2, pp. 369–371, 2014. View at Publisher · View at Google Scholar
  21. C. R. Hooijmans, M. Leenaars, and M. Ritskes-Hoitinga, “A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible,” Alternatives to Laboratory Animals, vol. 38, no. 2, pp. 167–182, 2010. View at Google Scholar · View at Scopus
  22. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” Annals of Internal Medicine, vol. 151, no. 4, pp. 264–269, 2009. View at Publisher · View at Google Scholar
  23. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials,” Annals of Internal Medicine, vol. 152, no. 11, pp. 726–732, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Kilkenny, W. J. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, “Improving bioscience research reporting: the arrive guidelines for reporting animal research,” Animals, vol. 4, no. 1, pp. 35–44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Ren, Y. Zhang, W. Cui et al., “A polysaccharide extract of mulberry leaf ameliorates hepatic glucose metabolism and insulin signaling in rats with type 2 diabetes induced by high fat-diet and streptozotocin,” International Journal of Biological Macromolecules, vol. 72, pp. 951–959, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Miura, H. Ichiki, I. Hashimoto et al., “Antidiabetic activity of a xanthone compound, mangiferin,” Phytomedicine, vol. 8, no. 2, pp. 85–87, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. G. B. Kavishankar and N. Lakshmidevi, “Anti-diabetic effect of a novel N-Trisaccharide isolated from Cucumis prophetarum on streptozotocin-nicotinamide induced type 2 diabetic rats,” Phytomedicine, vol. 21, no. 5, pp. 624–630, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Moser, S. P. Vickers, R. Brammer, S. C. Cheetham, and J. Drewe, “Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice,” Phytomedicine, vol. 21, no. 11, pp. 1382–1389, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. C.-T. Ruan, S.-H. Lam, T.-C. Chi, S.-S. Lee, and M.-J. Su, “Borapetoside C from Tinospora crispa improves insulin sensitivity in diabetic mice,” Phytomedicine, vol. 19, no. 8-9, pp. 719–724, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Sato, T. Tai, Y. Nunoura, Y. Yajima, S. Kawashima, and K. Tanaka, “Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin,” Biological and Pharmaceutical Bulletin, vol. 25, no. 1, pp. 81–86, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-C. Lo, F.-A. Tsai, S. P. Wasser, J.-G. Yang, and B.-M. Huang, “Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats,” Life Sciences, vol. 78, no. 17, pp. 1957–1966, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Yoshida, H. Seino, Y. Ito et al., “Inhibition of glycogen synthase kinase-3β by falcarindiol isolated from Japanese parsley (Oenanthe javanica),” Journal of Agricultural and Food Chemistry, vol. 61, no. 31, pp. 7515–7521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Krenisky, J. Luo, M. J. Reed, and J. R. Carney, “Isolation and antihyperglycemic activity of bakuchiol from Otholobium pubescens (Fabaceae), a Peruvian medicinal plant used for the treatment of diabetes,” Biological and Pharmaceutical Bulletin, vol. 22, no. 10, pp. 1137–1140, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Zhao, B. Qiu, Q. Li et al., “LBP-4a improves insulin resistance via translocation and activation of GLUT4 in OLETF rats,” Food and Function, vol. 5, no. 4, pp. 811–820, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. R. M. Perez-Gutierrez and M. Damian-Guzman, “Meliacinolin: a potent α-glucosidase and α-amylase inhibitor isolated from Azadirachta indica leaves and in vivo antidiabetic property in streptozotocin-nicotinamide-induced type 2 diabetes in mice,” Biological and Pharmaceutical Bulletin, vol. 35, no. 9, pp. 1516–1524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Luo, J. Cheung, E. M. Yevich et al., “Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes,” Journal of Pharmacology and Experimental Therapeutics, vol. 288, no. 2, pp. 529–534, 1999. View at Google Scholar · View at Scopus
  37. D. Y. Kwon, Y. S. Kim, S. Y. Ryu et al., “Platyconic acid, a saponin from Platycodi radix, improves glucose homeostasis by enhancing insulin sensitivity in vitro and in vivo,” European Journal of Nutrition, vol. 51, no. 5, pp. 529–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Chen, M. Ma, Y. Lu, L. Wang, C. Wu, and H. Duan, “Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice,” Planta Medica, vol. 75, no. 5, pp. 472–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-Y. Hsu, H.-Y. Shih, Y.-C. Chia et al., “Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation,” Molecular Nutrition and Food Research, vol. 58, no. 6, pp. 1168–1176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Kumar, D. K. Patel, S. K. Prasad, D. Laloo, S. Krishnamurthy, and S. Hemalatha, “Type 2 antidiabetic activity of bergenin from the roots of Caesalpinia digyna Rottler,” Fitoterapia, vol. 83, no. 2, pp. 395–401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Zhang, J.-B. Wang, L. Wang, L.-Y. Zhen, Q.-Q. Zhu, and X.-W. Chen, “A study on hypoglycaemic health care function of Stigma maydis polysaccharides,” African Journal of Traditional, Complementary, and Alternative Medicines, vol. 10, no. 5, pp. 401–407, 2013. View at Google Scholar · View at Scopus
  42. R. Agrawal, N. K. Sethiya, and S. H. Mishra, “Antidiabetic activity of alkaloids of Aerva lanata roots on streptozotocin-nicotinamide induced type-II diabetes in rats,” Pharmaceutical Biology, vol. 51, no. 5, pp. 635–642, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Paramaguru, P. M. Mazumder, D. Sasmal, and V. Jayaprakash, “Antidiabetic activity of Pterospermum acerifolium flowers and glucose uptake potential of bioactive fraction in L6 muscle cell lines with its HPLC fingerprint,” BioMed Research International, vol. 2014, Article ID 459376, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Chakrabarti, T. K. Biswas, T. Seal et al., “Antidiabetic activity of Caesalpinia bonducella F. in chronic type 2 diabetic model in Long-Evans rats and evaluation of insulin secretagogue property of its fractions on isolated islets,” Journal of Ethnopharmacology, vol. 97, no. 1, pp. 117–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Kiho, M. Kochi, S. Usui, K. Hirano, K. Aizawa, and T. Inakuma, “Antidiabetic effect of an acidic polysaccharide (TAP) from Tremella aurantia and its degradation product (TAP-H),” Biological and Pharmaceutical Bulletin, vol. 24, no. 12, pp. 1400–1403, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Fujii, I. Takei, and K. Umezawa, “Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-treated and Goto-Kakizaki rats,” Biomedicine & Pharmacotherapy, vol. 63, no. 10, pp. 710–716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Chen, H. Xiong, J. Wang, X. Ding, G. Shu, and Z. Mei, “Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats,” Journal of Ethnopharmacology, vol. 149, no. 3, pp. 729–736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. S. D. Klomann, A. S. Mueller, J. Pallauf, and M. B. Krawinkel, “Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice,” British Journal of Nutrition, vol. 104, no. 11, pp. 1613–1620, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Arya, C. Yeng Looi, S. Chuen Cheah, M. Rais Mustafa, and M. Ali Mohd, “Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats,” Journal of Ethnopharmacology, vol. 144, no. 1, pp. 22–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. M. A. Ibrahim and M. S. Islam, “Anti-diabetic effects of the acetone fraction of Senna singueana stem bark in a type 2 diabetes rat model,” Journal of Ethnopharmacology, vol. 153, no. 2, pp. 392–399, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Ganeshpurkar, S. Kohli, and G. Rai, “Antidiabetic potential of polysaccharides from the white oyster culinary-medicinal mushroom Pleurotus florida (higher Basidiomycetes),” International Journal of Medicinal Mushrooms, vol. 16, no. 3, pp. 207–217, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. X.-S. Shu, J.-H. Lv, J. Tao, G.-M. Li, H.-D. Li, and N. Ma, “Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 539–543, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Roman-Ramos, J. C. Almanza-Perez, A. Fortis-Barrera et al., “Antioxidant and anti-inflammatory effects of a hypoglycemic fraction from Cucurbita ficifolia Bouché in streptozotocin-induced diabetes mice,” American Journal of Chinese Medicine, vol. 40, no. 1, pp. 97–110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Zhao, Q. Li, and B. Xiao, “Effect of Lycium barbarum polysaccharide on the improvement of insulin resistance in NIDDM rats,” Yakugaku Zasshi, vol. 125, no. 12, pp. 981–988, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. I. K. Hwang, D. W. Kim, J. H. Park et al., “Effects of grape seed extract and its ethylacetate/ethanol fraction on blood glucose levels in a model of type 2 diabetes,” Phytotherapy Research, vol. 23, no. 8, pp. 1182–1185, 2009. View at Publisher · View at Google Scholar
  56. Y. Wu, J.-P. Ou-Yang, K. Wu, Y. Wang, Y.-F. Zhou, and C.-Y. Wen, “Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B,” Acta Pharmacologica Sinica, vol. 26, no. 3, pp. 345–352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Xu, Y. Wang, D.-S. Xu, K.-F. Ruan, Y. Feng, and S. Wang, “Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus,” International Journal of Biological Macromolecules, vol. 49, no. 4, pp. 657–662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Costantino, L. Raimondi, R. Pirisino et al., “Isolation and pharmacological activities of the Tecoma stans alkaloids,” Il Farmaco, vol. 58, no. 9, pp. 781–785, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. S. K. Bharti, A. Kumar, N. K. Sharma et al., “Tocopherol from seeds of Cucurbita pepo against diabetes: Validation by in vivo experiments supported by computational docking,” Journal of the Formosan Medical Association, vol. 112, no. 11, pp. 676–690, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Kharbanda, M. Sarwar Alam, H. Hamid et al., “Trapa natans L. root extract suppresses hyperglycemic and hepatotoxic effects in STZ-induced diabetic rat model,” Journal of Ethnopharmacology, vol. 151, no. 2, pp. 931–936, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Yu, L. Zheng, L. Xu et al., “Potent effects of the total saponins from Dioscorea nipponica Makino against streptozotocin-induced type 2 diabetes mellitus in rats,” Phytotherapy Research, vol. 29, no. 2, pp. 228–240, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Zucker and A. K. Beery, “Males still dominate animal studies,” Nature, vol. 465, no. 7299, p. 690, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. C. C. Machado and R. A. Zatti, “Animais de laboratório: o camundongo,” Anais V SIMPAC, vol. 5, no. 1, pp. 169–176, 2013. View at Google Scholar
  64. C. Kilkenny, W. J. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, “Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research,” Animals, vol. 4, no. 1, pp. 35–44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. B. J. Goud, V. Dwarakanath, and B. K. Chikka, “Streptozotocin-a diabetogenic agent in animal models,” International Journal of Pharmacy & Pharmaceutical Research, vol. 3, pp. 254–269, 2015. View at Google Scholar
  66. B. L. Furman, “Streptozotocin-induced diabetic models in mice and rats,” Current Protocols in Pharmacology, vol. 70, p. 47, 2015. View at Google Scholar
  67. E. M. R. Neto, L. A. R. V. Marques, M. A. D. Ferreira et al., “Metformin: a review of the literature,” Saúde e Pesquisa, vol. 8, no. 2, pp. 355–362, 2015. View at Google Scholar
  68. S.-C. Shen and W.-C. Chang, “Hypotriglyceridemic and hypoglycemic effects of vescalagin from Pink wax apple [Syzygium samarangense (Blume) Merrill and Perry cv. Pink] in high-fructose diet-induced diabetic rats,” Food Chemistry, vol. 136, no. 2, pp. 858–863, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Wang, T. Campbell, B. Perry, C. Beaurepaire, and L. Qin, “Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats,” Metabolism: Clinical and Experimental, vol. 60, no. 2, pp. 298–305, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Zheng, G. Shu, Z. Yang, S. Mo, Y. Zhao, and Z. Mei, “Antidiabetic effect of total saponins from Entada phaseoloides (L.) Merr. in type 2 diabetic rats,” Journal of Ethnopharmacology, vol. 139, no. 3, pp. 814–821, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. G. Negri, “Diabetes melito: plantas e princípios ativos naturais hipoglicemiantes,” Revista Brasileira de Ciências Farmacêuticas, vol. 41, no. 2, pp. 121–142, 2005. View at Publisher · View at Google Scholar
  72. A. L. Al-Malki, “Inhibition of α-glucosidase by thiosulfinate as a target for glucose modulation in diabetic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 7687915, 5 pages, 2016. View at Publisher · View at Google Scholar
  73. R. D. Wilson and M. S. Islam, “Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes,” Pharmacological Reports, vol. 64, no. 1, pp. 129–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. V. A. Fonseca, “Defining and characterizing the progression of type 2 diabetes,” Diabetes Care, vol. 32, pp. S151–S156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Taha, A. Arya, M. Paydar et al., “Upregulation of insulin secretion and downregulation of pro-inflammatory cytokines, oxidative stress and hyperglycemia in STZ-nicotinamide-induced type 2 diabetic rats by Pseuduvaria monticola bark extract,” Food and Chemical Toxicology, vol. 66, pp. 295–306, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. A. D. S. E. Silva and M. P. G. Mota, “Efeitos dos programas de treinamento aeróbio, de força e combinado na glicose sanguínea em diabéticos do tipo 2: uma revisão sistemática,” Ciências em Saúde, vol. 5, pp. 61–74, 2015. View at Google Scholar
  77. R. Kumar, D. K. Pate, S. K. Prasad, K. Sairam, and S. Hemalatha, “Antidiabetic activity of alcoholic leaves extract of Alangium lamarckii Thwaites on streptozotocin-nicotinamide induced type 2 diabetic rats,” Asian Pacific Journal of Tropical Medicine, vol. 4, no. 11, pp. 904–909, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Das, A. Chaurasia, P. Sahu, V. K. Mishra, and S. Kashaw, “Antihypercholestrolemic potential of omega-3-fatty acid concentrate in alloxan induced diabetic rodent,” International Journal of Pharmaceutical Sciences and Research, vol. 6, pp. 3634–3640, 2015. View at Google Scholar
  79. L. Pari and R. Saravanan, “Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose mretabolism hyperglycaemic rats,” Diabetes, Obesity and Metabolism, vol. 6, no. 4, pp. 286–292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. N. S. Nagarajan, N. Murugesh, P. Thirupathy Kumaresan, N. Radha, and A. Murali, “Antidiabetic and antihyperlipemic effects of Clemeo felina,” Fitoterapia, vol. 76, no. 3-4, pp. 310–315, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. N. S. Virdi, P. Lefebvre, H. Parisé et al., “Association of self-monitoring of blood glucose use on glycated hemoglobin and weight in newly diagnosed, insulin-naïve adult patients with type 2 diabetes,” Journal of Diabetes Science and Technology, vol. 7, no. 5, pp. 1229–1242, 2013. View at Publisher · View at Google Scholar · View at Scopus